Chronomics of pressure overloadinduced cardiac hypertrophy in mice reveals altered day night gene expression and biomarkers of heart disease

Chronobiology International

Volumn 29, Issue 7, 2012, Pages 810-821

  Tsimakouridze, Elena V ^a   Straume, Marty ^b   Podobed, Peter S ^a   Chin, Heather ^a   Lamarre, Jonathan ^a   Johnson, Ron ^a   Antenos, Monica ^a   Kirby, Gordon M ^a   MacKay, Allison ^a   Huether, Patsy ^a   Simpson, Jeremy A ^a   Sole, Michael ^c   Gadal, Gerard ^a   Martino, Tami A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b COBRA ^*  (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Biomarkers; Cardiovascular; Circadian; Gene expression profiles; Microarrays; Remodeling

Indexed keywords

MURINAE; MUS;

BIOLOGICAL MARKER; ION CHANNEL; KIF5B PROTEIN, MOUSE; KINESIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTOME;

ANIMAL; ARTICLE; BLOOD PRESSURE; C57BL MOUSE; CARDIOMEGALY; CIRCADIAN RHYTHM; DISEASE COURSE; DISEASE MODEL; DNA MICROARRAY; GENETICS; HEART VENTRICLE REMODELING; HUMAN; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN MICROARRAY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOMEGALY; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; ION CHANNELS; KINESIN; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTOME; VENTRICULAR REMODELING;

EID: 84864271267     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.691145     Document Type: Article

References (57)

1. Baker KM, Booz GW, Dostal DE. (1992). Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 54:227-241.
2. Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JR, Litwin SE, Hardin PE, Chow CW, Chandler MP, Abel, ED. Young ME. (2008). Disruption of the circadian clock within the car-diomyocyte influences myocardial contractile function, metabolism, and gene expression. Am. J. Physiol. Heart Circ. Physiol. 294:H1036-H1047.
3. Buermans HP, Redout EM, Schiel AE, Musters RJ, Zuidwijk M, Eijk PP, van Hardeveld C, Kasanmoentalib S, Visser FC, Ylstra B, Simonides WS. (2005). Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol. Genomics 21:314-323.
4. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, Di Vito L, Carlini D, Silvestri L, Brugaletta S, Liuzzo G, Créa F, Capo-grossi MC. (2009). Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol. Genomics 38:233-240.
5. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. (1997). Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol. 79:1512-1516.
6. Dardente H, Menet JS, Challet E, Tournier BB, Pévet P, Masson-Pévet M. (2004). Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents. Brain. Res. Mol. Brain. Res. 124:143-151.
7. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Reiter RJ. (2006). Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am. J. Cardiol. 97:1162-1164.
8. Durgan DJ, Young ME. (2010). The cardiomyocyte circadian clock: emerging roles in health and disease. Circ. Res. 106:647-658.
9. Durgan DJ, Moore MW, Ha NP, Egbejimi O, Fields A, Mbawuike U, Egbejimi A, Shaw CA, Bray MS, Nannegari V, Hickson-Bick DL, Heird WC, Dyck JR, Chandler MP, Young ME. (2007). Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. Am. J. Physiol. Heart Circ. Physiol. 293: H2385-H2393.
10. Durgan DJ, Tsai J-Y, Grenett MH, Pat BM, Ratcliffe WF, Villegas-Montoya C, Garvey ME, Nagendran J, Dyck RB, Bray MS, Gamble KL, Gimble JM, Young ME. (2011). Evidence suggesting that the cardiocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice. Chronobiol. Int. 28:177-186.
11. Ghazalpour A, Bennett B, Petyuk VA, Orozco L, Hagopian R, Mungrue IN, Farber CR, Sinsheimer J, Kang HM, Furlotte N, Park CC, Wen PZ, Brewer H, Weitz K, Camp DG2nd, Pan C, Yordanova R, Neuhaus I, Tilford C, Siemers N, Gargalovic P, Eskin E, Kirchgess-ner T, Smith DJ, Smith RD, Lusis AJ. (2011). Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet. 7: el001393.
12. Grond-Ginsbach C, Hummel M, Wiest T, Horstmann S, Pfleger K, Hergenhahn M, Hollstein M, Mansmann U, Grau AJ, Wagner S. (2008). Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J. Neurol. 255:723-731.
13. Guo YF, Stein PK (2003). Circadian rhythm in the cardiovascular system: chronocardiology. Am. Heart J. 145:779-786.
14. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749-775.
15. Hermida RC, Ayala DE, Fernandez JR, Calvo C. (2008). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69-76.
16. Hermida RC, Ayala DE, Mojón A, Fernandez Jr. (2010a). Influence of circadian time of hypertension treatment on cardiovascular risk results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
17. Hermida RC, Ayala DE, Fontao MJ, Alonso I, Fernandez Jr. (2010b). Administration-time-dependent effects of Spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol. Int. 27:560-574.
18. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK, Edwards DR, Liu PP, Backx PH, Khokha R. (2005). Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ. Res. 97:380-390.
19. Kumaki Y, Ukai-Tadenuma M, Uno KD, Nishio J, Masumoto KH, Nagano M, Komori T, Shigeyoshi Y, Hogenesch JB, Ueda HR. (2008). Analysis and synthesis of high-amplitude Cis-elements in the mammalian circadian clock. Proc. Natl. Acad. Sei. U. S. A. 105:14946-14951.
20. Leibetseder V, Humpeler S, Svoboda M, Schmid D, Thalhammer T, Zuckermann A, Marktl W, Ekmekcioglu C. (2009). Clock genes display rhythmic expression in human hearts. Chronobiol. Int. 26:621-636.
21. Martino TA, Sole MJ. (2009). Molecular time: an often overlooked dimension to cardiovascular disease. Circ. Res. 105:1047-1061.
22. Martino T, Arab S, Straume M, Belsham DD, Tata N, Cai F, Liu P, Trivieri M, Ralph M, Sole MJ. (2004). Day/night rhythms in gene expression of the normal murine heart. J. Mol. Med. 82:256-264
23. Martino TA, Tata N, Belsham DD, Chalmers J, Straume M, Lee P, Pribiag H, Khaper N, Liu PP, Dawood F, Bad PH, Ralph MR, Sole MJ. (2007a). Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchroni-zation. Hypertension 49:1104-1113.
24. Martino TA, Tata N, Bjarnason GA, Straume M, Sole MJ. (2007b). Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R1430-R1437.
25. Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, Husain M, Heximer S, Backx PH, Sole MJ. (2011). The primary benefits of angiotensin-convert-ing enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J. Am. Coll. Cardiol. 57:2020-2028.
26. Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR, Pedrazzini T. (1998). Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31:1324-1330.
27. Mirotsou M, Watanabe CM, Schultz PG, Pratt RE, Dzau VJ. (2003). Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol. Genomics 15:115-126.
28. Mitchell S, Ota A, Foster W, Zhang B, Fang Z, Patel S, Nelson SF, Horvath S, Wang Y. (2006). Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation. Physiol. Genomics 25:50-59.
29. Moore DF, Li H, Jeffries N, Wright V, Cooper RA, Elkahloun A, Gelder-man MP, Zudaire E, Blevins G, Yu H, Goldin E, Baird AE. (2005). Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 111:212-221.
30. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Kenneth Poole W, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E, the MILIS Study Group. (1985). Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 313:1315-1322.
31. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. (1987). Circadian variation in the frequency of sudden cardiac death. Circulation 75:131-138.
32. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. (2002). Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension 40:827-833.
33. O'Neill JS, Reddy AB. (2011). Circadian clocks in human red blood cells. Nature 469:498-503.
34. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. (2002a). Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109:307-320.
35. Panda S, Hogenesch JB, Kay SA. (2002b). Circadian rhythms from flies to human. Nature 417:329-335.
36. Podobed PS, Kirby GM, Martino TA. (2012). Circadian proteomics and its unique advantage for discovery of biomarkers of heart disease. In Man TK, Flores RJ(eds.). Proteomics. Human diseases and protein functions. Croatia: InTech, 65-88.
37. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronother-apy of hypertenmsion based on the MAPEC study. Chronobiol. Int. 27:152-1667.
38. Portaluppi F, Smolensky MH, Touitou Y (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
39. Qiu YG, Zhu JH, Tao QM, Zheng P, Chen JZ, Hu SJ, Zhang FR, Zheng LR, Zhao LL, Yao XY. (2005). Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. Cardiovasc. Drugs. Ther. 19:189-195.
40. Radha E, Hill TD, Rao GH, White JG. (1985). Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb. Res. 40:823-831.
41. Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature 418:935-941.
42. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J, Chien KR. (1991). Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sei. U. S. A. 88:8277-8281.
43. Roenneberg T, Merrow M. (2005). Timeline: circadian clocks-the fall and rise of physiology. Nat. Rev. Mol. Cell. Biol. 6:965-971.
44. Scheer FA, Michelson AD, Frelinger AL 3rd, Evoniuk H, Kelly EE, McCarthy M, Doamekpor LA, Barnard MR, Shea SA. (2011). The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS ONE 6:e24549.
45. Shaw EE, Wood P, Kulpa J, Yang FH, Summerlee AJ, Pyle WG. (2009). Relaxin alters cardiac myofilament function through a PKC-depen-dent pathway. Am. J. Physiol. Heart Circ. Physiol. 297:H29-H36.
46. Smolensky MH, Haus E. (2001). Circadian rhythms and clinical medicine with applications to hypertension. Am. J. Hypertens. 14: p280S-290S.
47. Smolensky MH, Hermida R, Ayala DE, Portaluppi F. (2010). Administration-time-dependent effects of antihypertension medications: basis for the chronotherapy of hypertension review.Blood Press. Monit. 15:173-180.
48. Sole MJ, Martino TA. (2009). Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J. Appl. Physiol. 107:1318-1327.
49. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ. (2002). Extensive and divergent circadian gene expression in liver and heart. Nature 417:78-83.
50. Tabibiazar R, Wagner RA, Liao A, Quertermous T. (2003). Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ. Res. 93:1193-1201.
51. Tsai JY, Kienesberger PC, Pulinilkunnil T, Sailors MH, Durgan DJ, Villegas-Montoya C, Jahoor A, Gonzalez R, Garvey ME, Boland B, BlasierZ, McElfreshTA, NannegariV, ChowCW, HeirdWC, Chandler MP, Dyck JR, Bray MS, Young ME. (2010). Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. J. Biol. Chem. 285:2918-2929.
52. Ueda HR, Chen W, Minami Y, Honma S, Honma K, lino M, Hashimoto S. (2004). Molecular-timetable methods for detection of body time and rhythm disorders from single-time-point genome-wide expression profiles. Proc. Natl. Acad. Sei. U. S. A. 101:11227-11232.
53. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldri-ni F, Porcellati C. (1990). Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528-536.
54. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. (1987). Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am. J. Cardiol. 60:801-806.
55. Young ME. (2006). The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am. J. Physiol. Heart Circ. Physiol. 290:H1-H16.
56. Young ME, Razeghi P, Taegtmeyer H. (2001a). Clock genes in the heart: characterization and attenuation with hypertrophy. Circ. Res. 88:1142-1150.
57. Young ME, Razeghi P, Cedars AM, Guthrie PH, Taegtmeyer H. (2001b). Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ. Res. 89:1199-1208.